A. D. C. 华盛顿市 巡回法院斥责缉毒局延缓了Ayahuasca和大麻登记决定,2018年的申请被置于监管禁闭状态。 A D.C. Circuit Court rebuked the DEA for stalling ayahuasca and marijuana registration decisions, with a 2018 application stuck in regulatory limbo.

A. D. C. 华盛顿市 A D.C. 巡回法院严厉批评缉毒局在处理两项引人注目的申请方面拖延了多年:对阿亚瓦斯卡人使用的宗教豁免和大麻制造登记。 Circuit Court has sharply criticized the DEA for years-long delays in processing two high-profile applications: a religious exemption for ayahuasca use and a marijuana manufacturing registration. 法官质疑该机构的不作为,指出一年多来没有取得任何进展,而司法部承认DEA的内部法庭制度违宪。 Judges questioned the agency’s inaction, noting no progress in over a year, while the Department of Justice conceded the DEA’s internal tribunal system is unconstitutional. 尽管如此,尚未就MMJ BioPharma的2018年申请作出最后决定,该申请在管制性Catch-22中仍然停滞不前:DEA要求在登记前签订供应协议,但联邦法律禁止在批准登记之前签订此类协议。 Despite this, no final decision has been made on MMJ BioPharma’s 2018 application, which remains stalled in a regulatory Catch-22: the DEA requires a supply agreement before registration, but federal law prohibits such agreements until registration is granted. MMJ警告称，如果没有采取行动，可能会在2026年1月28日前提起诉讼，这与爱荷华州教会提出强制令请愿的做法类似。 MMJ warns it may sue by January 28, 2026, if no action occurs, mirroring the Iowaska Church’s mandamus petition to force the agency to act.